News About: Pharm. Industry
56 pharmaceutical firms see stock assets go up
The aggregate market values of Korean drugmakers that went public on the local bourse rose by 2.3 percent this year, latest data showed.
According to Yakup.com, an online information provider on the nation’s drugma...
Sanofi-Aventis Korea joins KDRA
Sanofi-Aventis Korea has recently joined the Korea Drug Research Association (KDRA) as a full-fledged member.
The KDRA has 54 member companies focusing on research and development (R&D), with 260 affiliated researc...
Chong Kun Dang to turn into holding company
Chong Kun Dang Pharmaceutical said Monday it plans to split the company into two parts of holding and operating firms on November 2 in an effort to streamline the corporate structure, while adding a variety of operati...
John Whang named CFO of AstraZeneca KoreaAstraZeneca Korea said Monday it has appointed as its chief finance officer (CFO), John Whang, a renowned expert in finance and accounting with some 20 years of related expertis...
|
Celltrion’s biosimilar Remsima gets EU green light
Biopharmaceutical company Celltrion said Monday its biosimilar monoclonal antibody Remsima has won approval by the European Medicines Agency, setting out a clearer path for the local drugmaker to export the drug to 30...
Ilang to work with its Chinese arm on Supect
Ilyang Pharmaceutical announced last Saturday that it signed a memorandum of understanding with its Chinese arm Yangzhou Ilyang Pharmaceutical in China for the production and sales of Supect (rodotinib).
Yangzhou I...
Drug companies rush to hike OTC prices
Some drug companies here are jumping on the bandwagon to hike prices of medicines, many of which are over-the-counter products produced by multinational giants, raising a concern that this puts a heavier financial bur...
Green Cross breaks off acquisition talks for Plasma Resources UK
Green Cross Corporation, which had shown a keen interest in taking over Plasma Resources UK, a blood plasma corporation, withdrew as it lost interest in the purchase.
On Thursday, the company said in a regulatory f...
Multinational giants pin hopes on wider insurance coverage
Riding on the government’s plan to broaden coverage of expenses related to the so-called four major illnesses, which was made public yesterday, multinational drug firms expect that their new anticancer drugs with a hi...
Handok Pharmaceutical changes name to Handok
Handok Pharmaceutical plans to change its name to Handok from July 1.
“The change of company name represents our resolve to open a new chapter of change and innovation as a new total healthcare company based on spl...
